Abstract:Fan Li, 1– 3, &ast Zhengjian Wang, 4, &ast Yinan Cao, 1– 3 Boliang Pei, 1– 3 Xinyu Luo, 1– 3 Jin Liu, 1– 3 Peng Ge, 1– 3 Yalan Luo, 1– 3 Shurong Ma, 1, 3 Hailong Chen 1– 3 1 Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China; 2 Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China; 3 Laboratory of Integrative Medicine, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, People's Republic of China; 4 Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shurong Ma; Hailong Chen, Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Zhongshan Road 222, Dalian, Liaoning, 116011, People's Republic of China, Tel +86-411-83635963, Fax +86-411-83622844, Email ; The pathogenesis of severe acute pancreatitis-associated acute lung injury (SAP-ALI), which is the leading cause of mortality among hospitalized patients in the intensive care unit, remains incompletely elucidated. The intestinal mucosal immune barrier is a crucial component of the intestinal epithelial barrier, and its aberrant activation contributes to the induction of sustained pro-inflammatory immune responses, paradoxical intercellular communication, and bacterial translocation. In this review, we firstly provide a comprehensive overview of the composition of the intestinal mucosal immune barrier and its pivotal roles in the pathogenesis of SAP-ALI. Secondly, the mechanisms of its crosstalk with gut microbiota, which is called gut-lung axis, and its effect on SAP-ALI were summarized. Finally, a number of drugs that could enhance the intestinal mucosal immune barrier and exhibit potential anti-SAP-ALI activities were presented, including probiotics, glutamine, enteral nutrition, and traditional Chinese medicine (TCM). The aim is to offer a theoretical framework based on the perspective of the intestinal mucosal immune barrier to protect against SAP-ALI. Keywords: severe acute pancreatitis-associated acute lung injury, intestinal mucosal immune barrier, gut microbiota, gut-lung axis, migration of immune cells Severe acute pancreatitis (SAP) is one of the most common abdominal critical emergencies in clinical practice. According to the 2012 Revision of the Atlanta Classification Standard (RAC) by the International AP Consensus and the 2014 Guidelines for diagnosis and treatment of the acute pancreatitis guide by the Chinese medical association branch, SAP is defined as acute inflammation of pancreas, and its main manifestations include pancreatic edema, necrosis, hemorrhage, infection, peripancreatic fluid collection, wall necrosis (WON), and extrapancreatic organ dysfunction or failure. 1,2 The main cause is the destruction of pancreatic acinar cells and bile duct cells, leading to the activation of trypsin and lipase in pancreatic tissue. 3,4 And it is often accompanied by organ failure lasting for more than 48 hours. The pathological process is characterized by an aggressive nature and the potential involvement of one or multiple organs, resulting in a mortality rate of up to 35% 5,6. The incidence of SAP has increased in recent years, with an estimated number of 110 to 140 cases per 100,000 population. 4,7–9 Acute lung jury is one of the most serious and earliest complications secondary to SAP, which usually manifests as a decrease in alveolar surface-active substances, an elevation in oxygen-free radicals and permeability of alveolar epithelial cells, accumulation of inflammatory proteins, and injury to the endothelial cells of the pulmonary microvasculature. This accounts for 70% of the mortality rate among patients with SAP. 10–12 The occurrence of SAP-ALI is typically accompanied by the release of inflammatory mediators in a cascading manner, disruption of the intestinal barrier function, imbalance of immune systems, as well as alterations in intestinal bacteria and their pathogen-associated molecular patterns (PAMPs). 13–16 SAP-ALI as a typical complication of SAP, is the main cause of death in SAP patients, and its mortality rate is more than 30%. 17–23 The current focus of SAP-ALI research is to find ways to reduce the inflammatory response and the expression of inflammatory factors. 24,25 Endotoxemia, systemic inflammatory response syndrome and multiple-organ fa -Abstract Truncated-

Regulation of Microtubule Stability in Pulmonary Microvascular Endothelial Cells in Rats with Severe Acute Pancreatitis: Qingyi Decoction is a Potential CDK5 Inhibitor

Establishment of the Critical Period of Severe Acute Pancreatitis-Associated Lung Injury.

Mechanism Investigation and Clinical Retrospective Evaluation of Qingyi Granules: Pancreas Cleaner About Ameliorating Severe Acute Pancreatitis with Acute Respiratory Distress Syndrome

Alleviation of acute pancreatitis-associated lung injury by inhibiting the p38 mitogen-activated protein kinase pathway in pulmonary microvascular endothelial cells

Traditional Chinese medicine, Qing Ying Tang, ameliorates the severity of acute lung injury induced by severe acute pancreatitis in rats via the upregulation of aquaporin-1

Ferroptosis in Rat Lung Tissue during Severe Acute Pancreatitis-Associated Acute Lung Injury: Protection of Qingyi Decoction

Pathological Changes in Multiple Organs of Rats with Severe Acute Pancreatitis Treated by Baicalin and Octreotide.

[Effect of Qingyi Decoction on gene expression profiles of severe acute pancreatitis rats by gene chip technique].

Study of the Protective Effects of Dexamethasone on Ileum Mucosa Injury in Rats with Severe Acute Pancreatitis.

Intestinal Mucosal Immune Barrier: A Powerful Firewall Against Severe Acute Pancreatitis-Associated Acute Lung Injury via the Gut-Lung Axis

Effect of Baicalin on Inflammatory Mediator Levels and Microcirculation Disturbance in Rats with Severe Acute Pancreatitis

Network Pharmacology and Experimental Validation of the Anti-Inflammatory Effect of Tingli Dazao Xiefei Decoction in Acute Lung Injury Treatment

Acadesine alleviates acute pancreatitis-related lung injury by mediating the barrier protective function of pulmonary microvascular endothelial cells

Qingyi decoction attenuates intestinal epithelial cell injury via the calcineurin/nuclear factor of activated T-cells pathway

Effects of Qing-Yi Decoction on Gene Expression Profile in Rats with Acute Necrotizing Pancreatitis

Da-Cheng-Qi decoction improves severe acute pancreatitis capillary leakage syndrome by regulating tight junction-associated proteins

Calycosin attenuates severe acute pancreatitis-associated acute lung injury by curtailing high mobility group box 1 - induced inflammation

Abdominal paracentesis drainage protects rats against severe acute pancreatitis-associated lung injury by reducing the mobilization of intestinal XDH/XOD

Mechanisms of Qingyi Decoction in Severe Acute Pancreatitis-Associated Acute Lung Injury via Gut Microbiota: Targeting the Short-Chain Fatty Acids-Mediated AMPK/NF-κB/NLRP3 Pathway

Modified Da-chai-hu Decoction regulates the expression of occludin and NF-κB to alleviate organ injury in severe acute pancreatitis rats

Qing-Yi Decoction in the Treatment of Acute Pancreatitis: An Integrated Approach Based on Chemical Profile, Network Pharmacology, Molecular Docking and Experimental Evaluation